| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.39B | 2.49B | 2.46B | 2.55B | 2.35B | 2.20B |
| Gross Profit | 640.80M | 660.30M | 644.50M | 696.80M | 664.80M | 635.30M |
| EBITDA | 511.20M | 561.70M | 591.30M | 547.00M | 569.20M | 531.70M |
| Net Income | 365.00M | 382.00M | 397.60M | 465.70M | 482.40M | 422.70M |
Balance Sheet | ||||||
| Total Assets | 6.58B | 6.69B | 7.00B | 6.86B | 6.59B | 5.55B |
| Cash, Cash Equivalents and Short-Term Investments | 1.02B | 1.02B | 1.19B | 1.07B | 928.90M | 1.43B |
| Total Debt | 681.70M | 682.20M | 664.40M | 665.10M | 665.90M | 303.20M |
| Total Liabilities | 2.98B | 3.13B | 3.44B | 3.53B | 3.45B | 2.38B |
| Stockholders Equity | 3.60B | 3.56B | 3.56B | 3.33B | 3.14B | 3.18B |
Cash Flow | ||||||
| Free Cash Flow | 157.70M | 192.10M | 232.00M | 408.50M | -130.80M | 329.30M |
| Operating Cash Flow | 157.80M | 193.10M | 233.40M | 410.50M | -129.50M | 331.70M |
| Investing Cash Flow | -11.50M | -4.00M | 60.90M | -12.80M | -27.70M | -6.60M |
| Financing Cash Flow | -260.60M | -365.90M | -172.70M | -256.20M | -342.10M | -535.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £3.21B | 5.48 | 10.20% | 6.38% | -6.44% | -0.03% | |
67 Neutral | £3.76B | 13.20 | 2.73% | 4.73% | 33.83% | 15.11% | |
63 Neutral | £3.11B | 37.90 | 2.40% | 8.95% | 4.21% | -65.57% | |
62 Neutral | £2.39B | 8.04 | 4.43% | 2.62% | 16.91% | 20.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | £3.77B | 15.22 | 8.05% | 4.54% | 16.74% | -0.16% | |
54 Neutral | £1.14B | 15.19 | 4.20% | ― | -0.57% | -104.08% |